Categories AlphaGraphs, Earnings

Bajaj Healthcare Q2 FY26 Earnings Results

Bajaj Healthcare Ltd, incorporated in 1993, specializes in the production of Active Pharmaceutical Ingredients (APIs) and pharmaceutical formulations with a strong global footprint. The company supplies to both advanced and emerging markets, ensuring regulatory compliance and product innovation.

Q2 FY26 Earnings Summary 

  • Consolidated revenue grew 11.28% year on year to ₹148 crore, up from ₹133 crore.\
  • Total expenses increased 8.06% to ₹134 crore, compared to ₹124 crore last year.
  • Consolidated net profit rose 22.22% to ₹11 crore, versus ₹9 crore in Q2 FY25.
  • Earnings per share (EPS) was ₹3.52, up 17.33% from ₹3.00 a year ago.

Operational and Business Highlights

  • Q2 FY26 saw strong growth in API exports (up 67% YoY), offsetting a slight decline in domestic API performance.
  • Formulation business remained stable with ongoing resilience despite a minor revenue dip.
  • Margin expansion was driven by higher export volumes and operational efficiencies. Gross margin improved sequentially by 462 basis points to 50.8%. EBITDA margin expanded to 19.1%.icicidirect+1
  • Bajaj Healthcare received key regulatory nods: phase III clinical trials for Suvorexant and Cenobamate tablets, as well as new CEP and DMF filings in regulated markets.

Financial Strength and Outlook

  • The company maintained a solid balance sheet, enhanced regulatory preparedness, and strategic investments in R&D.
  • Management remains focused on expanding product registrations and targeting high-value therapeutic areas for long-term growth.
  • Bajaj Healthcare continues to leverage its global presence, compliance, and innovation to sustain earnings growth through FY26 and beyond.

Explore the company’s past earnings and latest concall transcripts, click here to visit the AlphaStreet India News Channel.

Q2 FY26

Most Popular

Cochin Shipyard Ltd (COCHINSHIP) Q4 FY22 Earnings Concall Transcript

Cochin Shipyard Limited (NSE:COCHINSHIP) Q4 FY22 Earnings Concall dated May. 26, 2022 Corporate Participants: Madhu S Nair -- Chairman & Managing Director Jose V J -- Director Finance Analysts: Vastupal Shah

All you need to know about Antony Waste Handling Cell in one article

Can you guess the name of the company that was listed during the IPO frenzy in 2020 and is the second largest player in the Indian municipal waste management industry?

Demystifying the Leading Non-Ferrous Recycling Company of India

“Hey, how is the market doing today?” “Oh!, its falling tremendously since morning” I am sure news like these might be a common topic of discussion for you nowadays. Interestingly,

Top